[ad_1] Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA). “Lupin today announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final […]
Biocon gets FDA nod for cancer drugs lenalidomide and dasatinib – CNBC TV18
[ad_1] Biotechnology firm Biocon Ltd on Tuesday (March 4) said its wholly-owned subsidiary, Biocon Pharma Ltd, has received final approvals from the US Food and Drug Administration (FDA) for its abbreviated new drug applications (ANDAs). Lenalidomide capsules, in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. Lenalidomide is a […]